CRISPR Therapeutics
Series BCRISPR Therapeutics raised €35M in a Series B round in Jun 2016. The company is based in Basel, Switzerland. Investors in the round: Clough Capital Partners, Franklin Templeton Investments, New Leaf Venture Partners and 1 other. Data as of Nov 2026.
Amount raised
€35M
€34,500,000
Native amount
34,500,000 EUR
Stage
Series B
series b
Investors
4
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €35M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
4 namedDate
Jun 2016
Round type
series b
Amount (EUR)
€35M